Chloropyramine BE study [Power / Sample Size]

posted by Elena777 – Belarus, 2019-03-13 17:17 (565 d 05:37 ago) – Posting: # 20022
Views: 2,531

Dear all! Please share any idea with me. Chloropyramine is an antiallergic drug. We need to conduct BE study with our chloropyramine tablet vs reference Suprastin. But I failed to find any useful data about pharmacokinetics as well as BE reports of other companies and PARs about drugs with such API. My colleagues failed as well. So we have NO information about CVintra and CI for Cmax and AUCt. And we are not able even to suggest anything. There is nothing to rely on in estimation of sample size. Any help will be highly appreciated!

Complete thread:

Activity
 Admin contact
21,084 posts in 4,398 threads, 1,468 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Monday 23:55 CEST (Europe/Vienna)

A central lesson of science is that to understand complex issues
(or even simple ones), we must try to free our minds of dogma and
to guarantee the freedom to publish, to contradict, and to experiment.
Arguments from authority are unacceptable.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5